Benefits and safety of long-acting calcium antagonists in coronary artery disease: the Action Trial.
Fagard
Robert H
RH
Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, Faculty of Medicine, University of Leuven KU Leuven, Leuven, Belgium. robert.fagard@uz.kuleuven.ac.be
D002121:Calcium Channel Blockers / Q000008:administration & dosage* / Q000009:adverse effects; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000150:complications*; D009543:Nifedipine / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic
D002121:Calcium Channel Blockers; D009543:Nifedipine